title: Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression.
abstract: Psychomotor symptoms related to an impairment of the nigrostriatal dopaminergic system are frequent in major depression (MD). Repetitive transcranial magnetic stimulation (rTMS) has been discussed as a new treatment option for MD. In neurobiological terms, an influence of high-frequency rTMS on dopaminergic neurotransmission has previously been shown by several studies in animals and humans. Therefore, an improvement of psychomotor symptoms by rTMS could be assumed. The aim of this pilot study was to investigate the effect of high-frequency rTMS on psychomotor retardation and agitation in depressive patients. We investigated the effect of left prefrontal 10 Hz rTMS on psychomotor retardation and agitation in 30 patients with MD. Patients were randomly assigned to real or sham rTMS in addition to a newly initiated standardized antidepressant medication. We found a trend in the reduction of agitation (t(28) = 1.76, p = 0.09, two-tailed), but not in the reduction of retardation. Furthermore, no general additional antidepressant effect of rTMS was observed. Although there was no statistical significant influence of high-frequency rTMS on psychomotor symptoms in depressive patients, the results showed a trend in the reduction of psychomotor agitation in MD. This effect should be systematically investigated as the primary end point in further studies with larger sample sizes.
authors.affiliation: Department of Psychiatry and Psychotherapy, Center of Nervous Diseases, University of Rostock, Gehlsheimer Str. 20, 18147, Rostock, Germany. jacqueline.hoeppner@med.uni-rostock.de
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Hoeppner
authors.forename: Frank
authors.initials: F
authors.lastname: Padberg
authors.forename: Gregor
authors.initials: G
authors.lastname: Domes
authors.forename: Antonia
authors.initials: A
authors.lastname: Zinke
authors.forename: Sabine C
authors.initials: SC
authors.lastname: Herpertz
authors.forename: Nicola
authors.initials: N
authors.lastname: Grossheinrich
authors.forename: Uwe
authors.initials: U
authors.lastname: Herwig
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003865:Major Depressive Disorder / Q000150:complications / Q000628:therapy; D005260:Female; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D017397:Prefrontal Cortex / Q000502:physiology; D011596:Psychomotor Disorders / Q000209:etiology / Q000628:therapy*; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D050781:Transcranial Magnetic Stimulation / Q000379:methods*; D055815:Young Adult
references.citation: Arch Gen Psychiatry. 2005 Nov;62(11):1228-36
references.pmid: 16275810
references.citation: Brain. 2003 Dec;126(Pt 12):2609-15
references.pmid: 12937078
references.citation: Psychoneuroendocrinology. 2008 Jul;33(6):821-31
references.pmid: 18468810
references.citation: Am J Psychiatry. 2006 Sep;163(9):1594-602
references.pmid: 16946186
references.citation: Eur Arch Psychiatry Clin Neurosci. 2009 Feb;259(1):55-63
references.pmid: 18806921
references.citation: Br J Psychiatry. 2007 Nov;191:441-8
references.pmid: 17978325
references.citation: Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):92-7
references.pmid: 18806917
references.citation: Psychoneuroendocrinology. 2003 Apr;28(3):376-85
references.pmid: 12573303
references.citation: Am J Psychiatry. 2002 Aug;159(8):1427-9
references.pmid: 12153840
references.citation: Eur Arch Psychiatry Clin Neurosci. 2003 Apr;253(2):103-9
references.pmid: 12799750
references.citation: J Neurosci. 2001 Aug 1;21(15):RC157
references.pmid: 11459878
references.citation: J Psychiatr Res. 2006 Jun;40(4):307-14
references.pmid: 16259998
references.citation: Neurotox Res. 2004;6(4):317-25
references.pmid: 15545015
references.citation: Ann Neurol. 2002 May;51(5):599-603
references.pmid: 12112106
references.citation: Neuropharmacology. 2002 Jul;43(1):101-9
references.pmid: 12213264
references.citation: Mov Disord. 2007 Jun 15;22(8):1150-6
references.pmid: 17469208
references.citation: Acta Psychiatr Scand. 1999 Apr;99(4):252-6
references.pmid: 10223426
references.citation: J Pharmacol Sci. 2003 Dec;93(4):451-7
references.pmid: 14737016
references.citation: Brain. 2007 Jul;130(Pt 7):1799-807
references.pmid: 17329323
references.citation: J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):85-92
references.pmid: 9547471
references.citation: Psychol Med. 1987 Aug;17(3):609-19
references.pmid: 3628622
references.citation: Twin Res Hum Genet. 2006 Oct;9(5):632-6
references.pmid: 17032542
references.citation: Neuroreport. 2006 Nov 6;17(16):1703-7
references.pmid: 17047457
references.citation: Neuroreport. 2005 Oct 17;16(15):1715-8
references.pmid: 16189484
references.citation: J Affect Disord. 2000 Oct;60(1):1-11
references.pmid: 10940442